Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT – “Innovate”), a clinical stage biotechnology company focused on developing novel therapeutics announced the results from its February 14, 2020 special meeting of shareholders to approve proposals related to its upcoming merger with RDD Pharma Ltd. (“RDD”). At the Meeting, the stockholders approved all three proposals. Closing of the transformative transaction expected in early Q2 2020 upon completion of remaining closing conditions and receipt of regulatory approval in Israel.
Read the full article: Innovate Biopharmaceuticals Announces Shareholder Approval of All Proposals in Connection with the Pending Merger with RDD Pharma Ltd. //
Source: https://www.accesswire.com/576685/Innovate-Biopharmaceuticals-Announces-Shareholder-Approval-of-All-Proposals-in-Connection-with-the-Pending-Merger-with-RDD-Pharma-Ltd-to-Create-9-Meters-Biopharma-a-GI-focused-Platform-Company